A real world retrospective analysis of comparison of effectiveness and safety of mometasone furoate and fluticasone propionate in the management of eczema and dermatitis
| Autor: | R. D. Kharkar, Dhiraj Dhoot, Hanmant Barkate, Harshal Mahajan |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Mometasone business.industry Mometasone furoate Retrospective cohort study medicine.disease Dermatology Fluticasone propionate 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine medicine Retrospective analysis 030212 general & internal medicine business Medical science Contact dermatitis medicine.drug Fluticasone |
| Zdroj: | IP Indian Journal of Clinical and Experimental Dermatology. 7:120-124 |
| ISSN: | 2581-4729 2581-4710 |
| DOI: | 10.18231/j.ijced.2021.023 |
| Popis: | Contact dermatitis is one the commonest dermatological condition which is managed by topical corticosteroids. Mid potent topical corticosteroids are commonly prescribed but there is no any comparative data between mometasone furoate and fluticasone propionate in the management of dermatitis.A real world retrospective study was conducted across India to compare the clinical assessment of mometasone 0.1% cream and fluticasone 0.005% cream in the management of contact dermatitis at 236 dermatology clinics.A data of 1106 patients were included in this analysis in which 598 were included in mometasone group while 508 in fluticasone group. At the end of 2 weeks, 216 patients (36.1%) in mometasone and 129 patients (25.4%) in fluticasone group achieved complete clearance of symptoms (pBoth, mometasone furoate and fluticasone propionate were effective and safe in treatment of eczema/dermatitis. But mometasone furoate had shown significantly better effectiveness as compared to fluticasone in all predisposing factors for the disease. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|